Pharmaceutical Consultant on Adaptive Clinical Trial Design in 2016

Clinical trial consulting and pharmaceutical consulting professionals will benefit by becoming current on adaptive trial design. Gaining in popularity since the early 1990s,1 adaptive trials are those which observe patient outcomes after review of interim data and accommodate modifications to trial and/or statistical procedures.

Spotlight

Laboratorios Gebro Pharma

Laboratorios Gebro Pharma, SA, a Spanish subsidiary of the Austrian company Gebro Pharma GmbH, was established in March 2002, establishing its headquarters in Barcelona, and focused its main activity on the development and commercialization of treatments against pain and inflammation, making its way quickly in the areas of Rheumatology, Pain Units and Hospitals. Currently, Laboratorios Gebro Pharma is a company in full expansion, which has successful experiences in co-promotion and comarketing, with a team of more than 100 professionals and whose growth is one of the most outstanding in the Spanish pharmaceutical market in terms of billing and commercial coverage. .

OTHER WHITEPAPERS
news image

Streamlining Distribution in the Pharmaceutical Industry

whitePaper | November 25, 2022

Satyendra Sinha is a Functional Consultant with the TCS Life Sciences unit, and focuses on order management, distribution.

Read More
news image

Helping Patients Find and Engage with Clinical Trials

whitePaper | June 16, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible

Read More
news image

Pharma R&D Annual Review 2022

whitePaper | May 5, 2022

welcome to pharmaprojects'2022 review of trends in pharmaceutical R&D for 30 year now, I've been taking an anual look at the evloution of pharma

Read More
news image

Drug Solubility and the Need for Speed

whitePaper | March 28, 2023

About 70% of new chemical entities (NCEs) are highly insoluble.1 It’s a fact that troubles small biotechnology companies and other drug manufacturers. Indeed, insoluble drugs present a wide range of challenges during development and, if not addressed, can ultimately render drugs ineffective in patients.

Read More
news image

Sales coaching: preparing for the new reality in pharma

whitePaper | October 14, 2022

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment.

Read More
news image

PHARMACEUTICAL KEY ACCOUNT MANAGEMENT: HARNESSING SALES EXPERTISE TO DEVELOP UNIFIED STAKEHOLDER RELATIONSHIPS

whitePaper | November 25, 2022

To meet the needs of a growing range of external stakeholders, many life science companies are changing the ways that they disseminate information.

Read More

Spotlight

Laboratorios Gebro Pharma

Laboratorios Gebro Pharma, SA, a Spanish subsidiary of the Austrian company Gebro Pharma GmbH, was established in March 2002, establishing its headquarters in Barcelona, and focused its main activity on the development and commercialization of treatments against pain and inflammation, making its way quickly in the areas of Rheumatology, Pain Units and Hospitals. Currently, Laboratorios Gebro Pharma is a company in full expansion, which has successful experiences in co-promotion and comarketing, with a team of more than 100 professionals and whose growth is one of the most outstanding in the Spanish pharmaceutical market in terms of billing and commercial coverage. .

Events